Wound Care - LATAM

LATAM

Highlights

Revenue in the Wound Care market amounts to US$152.90m in 2024. The market is expected to grow annually by -0.87% (CAGR 2024-2028).
In global comparison, most revenue is generated United States (US$1bn in 2024).
In relation to total population figures, per person revenues of US$0.24 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureMethodology

The Wound Care market in LATAM is experiencing significant growth and development due to several factors. Customer preferences in the region are shifting towards advanced wound care products that offer better healing outcomes and improved patient comfort.

There is a growing demand for products such as wound dressings, wound closure devices, and negative pressure wound therapy systems. This shift is driven by an increasing awareness among healthcare professionals and patients about the benefits of advanced wound care products in reducing healing time and preventing complications. Trends in the market indicate a rising incidence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, in LATAM.

This is primarily attributed to the region's aging population and the high prevalence of chronic diseases, such as diabetes and cardiovascular diseases. As a result, there is a growing need for effective wound care solutions to manage and treat these chronic wounds. Local special circumstances in LATAM also contribute to the development of the Wound Care market.

Limited access to healthcare services in remote areas and underserved populations creates a demand for affordable and accessible wound care products. Additionally, the region's tropical climate and high humidity levels increase the risk of wound infections, making infection control a critical aspect of wound care management. Underlying macroeconomic factors, such as increasing healthcare expenditure and improving healthcare infrastructure, are driving the growth of the Wound Care market in LATAM.

Governments in the region are investing in healthcare reforms and initiatives to improve access to quality healthcare services, which includes wound care. This creates a favorable environment for market players to introduce innovative wound care products and expand their presence in the region. In conclusion, the Wound Care market in LATAM is developing rapidly due to changing customer preferences, rising incidence of chronic wounds, local special circumstances, and favorable macroeconomic factors.

Market players in the region have the opportunity to capitalize on this growth by offering advanced wound care solutions that meet the specific needs of healthcare professionals and patients in LATAM.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.